← Leaderboards
David R Plas
University Of Cincinnati
$6,272,213
Attributed
$6,272,213
Total exposure
4
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $434.4K · FY2005–24$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$6,272,213 · 4
By mechanism
R01$5,508,221 · 3
K01$763,992 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Cincinnati
Same institution · by research overlap
- George Thomas$8,900,710
Others in their field
Top investigators on “Metabolism”
- David M Nathan · Massachusetts Institute Of Technology$157,845,616
- Joseph J. Eron · Univ Of North Carolina Chapel Hill$144,157,234
- Judith S. Currier · University Of California Los Angeles$141,260,706
- John M Lachin · George Washington University$139,991,329
- Randall J Bateman · Washington University$124,168,384
- Carol Nesel · Westat$116,355,411
Research focus
MetabolismResponseMalignant NeoplasmsCellsSignal TransductionResistancePathway InteractionsMutationLeukemiaClinical TrialsMediatingMetabolicProgramsPten GeneApoptoticTumor Suppressor ProteinsProtein Tyrosine KinaseTyrosine Kinase InhibitorPreventCell SurvivalPhenotypeCell DeathProtein KinaseGlycolysis
Grant awards (20)
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma$400,209
R01 · FY2024 · CA · contact PI
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma$412,847
R01 · FY2023 · CA · contact PI
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma$412,847
R01 · FY2022 · CA · contact PI
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma$423,312
R01 · FY2021 · CA · contact PI
Co-targeting S6 and TAM kinases in PTEN-deficient glioblastoma$434,360
R01 · FY2020 · CA · contact PI
Metabolic Adaptive Responses in Cancer$416,900
R01 · FY2017 · CA · contact PI
Metabolic Adaptive Responses in Cancer$416,900
R01 · FY2016 · CA · contact PI
Metabolic Adaptive Responses in Cancer$417,215
R01 · FY2015 · CA · contact PI
Metabolic Adaptive Responses in Cancer$412,123
R01 · FY2014 · CA · contact PI
Metabolic Adaptive Responses in Cancer$427,706
R01 · FY2013 · CA · contact PI
Interrupting Akt-S6K1 metabolic control to enhance apoptotic responses in CML$261,901
R01 · FY2012 · CA · contact PI
Interrupting Akt-S6K1 metabolic control to enhance apoptotic responses in CML$261,901
R01 · FY2011 · CA · contact PI
Interrupting Akt-S6K1 metabolic control to enhance apoptotic responses in CML$270,000
R01 · FY2010 · CA · contact PI
Interrupting Akt-S6K1 metabolic control to enhance apoptotic responses in CML$270,000
R01 · FY2009 · CA · contact PI
Interrupting Akt-S6K1 metabolic control to enhance apoptotic responses in CML$270,000
R01 · FY2008 · CA · contact PI
Regulation of Cellular Survival, Size and Metabolism$159,462
K01 · FY2007 · CA · contact PI
Regulation of Cellular Survival, Size and Metabolism$159,462
K01 · FY2006 · CA · contact PI
Regulation of Cellular Survival, Size and Metabolism$159,462
K01 · FY2005 · CA
Regulation of Cellular Survival, Size and Metabolism$159,462
K01 · FY2004 · CA
Regulation of Cellular Survival, Size and Metabolism$126,144
K01 · FY2003 · CA